We are live on ! Find out more
AA

Antipodean Advisors Portfolio holdings

AUM $19.5M
1-Year Est. Return 6.21%
This Fund
S&P 500
This Quarter Est. Return
-38.34%
1 Year Est. Return
-6.21%
3 Year Est. Return
-67.79%
5 Year Est. Return
+67.26%
10 Year Est. Return
+1,117.22%
AUM
$138M
AUM Growth
-$105M
Cap. Flow
-$9.19M
Cap. Flow %
-6.65%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
RSX
VanEck Russia ETF
RSX
+$844K

Top Sells

Rank Stock Value
1
CLVT icon
Clarivate
CLVT
+$8.82M
2
CMAX
CareMax, Inc. Class A Common Stock
CMAX
+$1.21M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 65.34%
2 Communication Services 25.43%
3 Healthcare 9.03%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVNA icon
1
Carvana
CVNA
$47.5B
$48.3M 34.98%
2,025,000
– –
SE icon
2
Sea Limited
SE
$66.4B
$41.9M 30.36%
350,000
– –
CDLX icon
3
Cardlytics
CDLX
$22.2M
$35.1M 25.43%
63,880
– –
ATRA icon
4
Atara Biotherapeutics
ATRA
$72.6M
$9.29M 6.73%
40,000
– –
CMAX
5
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$3.17M 2.3%
14,167
-5,833
-29% -$1.21M
RSX
6
DELISTED
VanEck Russia ETF
RSX
$283K 0.2%
+50,000
New +$844K
CLVT icon
7
Clarivate
CLVT
$1.37B
– –
-375,000
Closed -$8.82M

Similar funds

CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
CCFM
Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return

Antipodean Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Antipodean Advisors held 7 positions worth $138M, down 43% from $244M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Antipodean Advisors withdrew a net $9.19M in Q1 2022, closing 1 position and reducing 1 holding. Its most notable exit was Clarivate, an estimated $8.82M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 65% of assets, down from 71% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Antipodean Advisors opened a new position in VanEck Russia ETF worth $283K.

  • Antipodean Advisors's largest Q1 2022 buy was VanEck Russia ETF: 50,000 shares worth $283K.
  • Antipodean Advisors's biggest Q1 2022 reduction was CareMax, Inc. Class A Common Stock, cutting an estimated $1.21M.
  • Antipodean Advisors fully exited Clarivate in Q1 2022, selling an estimated $8.82M.
  • Antipodean Advisors's ten largest holdings make up 100% of its $138M portfolio in Q1 2022.
  • Antipodean Advisors opened 1 new position and closed 1 in Q1 2022.
  • Antipodean Advisors's portfolio value fell 43% quarter-over-quarter to $138M.

Based on Antipodean Advisors's 13F filing for Q1 2022, filed 16 May 2022.